The protective effect of ACE2 expression and overexpression is well documented in the Coronaviridae family of viruses [77], as well as the corresponding depletion leading to worse outcomes in both peripheral and CNS tissues in SARS-CoV-1 and SARS-CoV-2 infection [12,78]. The gene discussed is ACE2; the disease is COVID-19.